Skip to content

Role of aganikarma with pippali and lauha salaka in the management of vatakantaka (heel pain)

Comparative clinical study to evaluate the therapeutic effect of aganikarma with pippali and lauha Shalaka in the management of vatakantaka (heel pain) - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093649
Enrollment
60
Registered
2025-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M05-M14- Inflammatory polyarthropathies

Interventions

None listed

Sponsors

DR PRAGYA SAHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. adult patient is 20 to 60 years who have been clinically diagnosed with varkantaka(heels pain) based on comprehensive physically examination. 2. Participants who are capable of providing informed consent and are willing to adhere in the study protocol, including all treatment sessions and follow up visit.

Exclusion criteria

Exclusion criteria: 1.Patients who are under gone similar ayurvedic or allopathic treatments for vatkantaka which could impact the efficacy of the interventions under investigation. 2. Major systematic disorders like RA . 3. Pregnancy and malignancy. 4. Uncontrolled diabetes ,known HIV , HBsAg positive patients are also excluded.

Design outcomes

Primary

MeasureTime frame
Evaluate the therapeutic effect of agnikarma with pippli and lauha shalakha in the managment of vatkantaka(heels pain)Timepoint: 8 weeks

Secondary

MeasureTime frame
To introduce the best & cost effective modality of treatment decrease risk of recurrence & fasten the recovery. Timepoint: After analysing all parameters the result will be assessed on the basis of symptomatic relief .

Countries

India

Contacts

Public ContactDR PRAGYA SAHU

Vaidya Yagya Dutt Sharma Ayurved Mahavidhalaya Khurja district Bulandshahar GT road

dr.arjunanil@gmail.com6360340886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026